The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements
- PMID: 27168728
- PMCID: PMC4859450
- DOI: 10.4137/BIC.S31802
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements
Abstract
Prostate cancer (PC) is the second most common form of cancer in men worldwide. Biomarkers have emerged as essential tools for treatment and assessment since the variability of disease behavior, the cost and diversity of treatments, and the related impairment of quality of life have given rise to a need for a personalized approach. High-throughput technology platforms in proteomics and genomics have accelerated the development of biomarkers. Furthermore, recent successes of several new agents in PC, including immunotherapy, have stimulated the search for predictors of response and resistance and have improved the understanding of the biological mechanisms at work. This review provides an overview of currently established biomarkers in PC, as well as a selection of the most promising biomarkers within these particular fields of development.
Keywords: biomarker; genomics; immunology; prostate cancer; proteomics.
References
-
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] 2013. [cited June 7, 2015]. Available at: http://globocan.iarc.fr.
-
- Society CC Prostate Cancer Statistics. 2015. [cited June 7, 2015]. Available at: http://www.cancer.ca/en/cancer-information/cancer-type/prostate/statisti....
-
- Society AC What are the Key Statistics About Prostate Cancer? 2015. [cited June 7, 2015]. Available at: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cance....
-
- Surveillance E; End Results Program (SEER) Surveillance, Epidemiology, and Ends Results Program. Fast Stats. 2015. [cited June 7, 2015]. Available at: http://seer.cancer.gov/faststats/selections.php.
-
- Mondo DM, Roehl KA, Loeb S, et al. Which is the most important risk factor for prostate cancer: race, family history, or baseline PSA level? J Urol. 2008;179(4):148.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources